TABLE 3.
Category | All patients, n (%) | Excluding those who needed IC by proxy a , n (%) |
---|---|---|
Any reaction after either dose | 138 (80.7%) | 109 (82.6%) |
First dose | (N = 171) | (N = 132) |
All | 104 (60.8%) | 85 (64.4%) |
Grade 1 | 79 (46.2%) | 69 (52.3%) |
Grade 2 | 20 (11.7%) | 13 (9.8%) |
Grade ≥3 | 2 (1.2%) | 2 (1.5%) |
Fever (>38.5°C) | 3 (1.8%) | 2 (1.5%) |
Second dose | (N = 170) | (N = 132) |
All | 115 (67.6%) | 93 (70.5%) |
Grade 1 | 83 (48.8%) | 71 (53.8%) |
Grade 2 | 27 (15.9%) | 20 (15.2%) |
Grade ≥3 | 3 (1.8%) | 2 (1.5%) |
Fever (>38.5°C) | 5 (2.9%) | 2 (1.5%) |
Severity was defined according to the Common Terminology Criteria for Adverse Events version 5.0.
Abbreviation: IC, informed consent (parents or siblings).